Supple Graphene Bio-Platform for point-of-care early detection and monitoring of Alzheimer’s Disease

2D-BioPAD

Start Date
End Date
Total Funding
€ 5 957 949
Funding Programme
EU-Horizon Europe
European Countries Involved

2D-BioPAD is a cost-effective, non-invasive point of care/self-testing tool for the early and accurate prognosis (assistive diagnosis) of Alzheimer's Disease, with special focus on earlier stages such as Subjective or Mild Cognitive Impairment (SCI/MCI).

Project partners

UNIVERZITA PALACKEHO V OLOMOUCI (CZ); UNIVERSITY COLLEGE DUBLIN
NATIONAL UNIVERSITY OF IRELAND
DUBLIN (IE); Q-PLAN INTERNATIONAL ADVISORS PC (EL); ARISTOTELIO PANEPISTIMIO THESSALONIKIS (EL); NOVAPTECH (FR); GRAPHEAL (FR); FUNDACIO INSTITUT CATALA DE NANOCIENCIA I NANOTECNOLOGIA (ES); ELLINIKI ETAIRIA NOSOY ALZHEIMER KAI SYGGENON DIATARACHON SOMATEIO (EL); ZENTRALINSTITUT FUER SEELISCHE GESUNDHEIT (DE); EVNIA APS (DK); ITA-SUOMEN YLIOPISTO (FI)
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).